Cargando…

CRISPR/Cas9-induced saturated mutagenesis identifies Rad51 haplotype as a marker of PARP inhibitor sensitivity in breast cancer

Breast cancer treatment with poly(ADP-ribose)polymerase (PARP) inhibitors is currently limited to cells defective in the homologous recombination repair (HRR) pathway. The chemical inhibition of many HRR deficiency genes may sensitize cancer cells to PARP inhibitors. In the present study, Rad51, a c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Hua, Wei, Yaning, Zhang, Qian, Yang, Yang, Bi, Xuebing, Yang, Lin, Xiao, Na, Zang, Aimin, Ren, Lili, Li, Xiaoli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309539/ https://www.ncbi.nlm.nih.gov/pubmed/35713220 http://dx.doi.org/10.3892/mmr.2022.12774

Ejemplares similares

CRISPR‐Cas9‐mediated efficient directed mutagenesis and RAD51‐dependent and RAD51‐independent gene targeting in the moss Physcomitrella patens
por: Collonnier, Cécile, et al.
Publicado: (2016)

Repression of mutagenesis by Rad51D-mediated homologous recombination
por: Hinz, John M., et al.
Publicado: (2006)

Elevated expression of exogenous RAD51 enhances the CRISPR/Cas9-mediated genome editing efficiency
por: Park, Seo Jung, et al.
Publicado: (2023)

Exploiting the CRISPR/Cas9 System for Targeted Genome Mutagenesis in Petunia
por: Zhang, Bin, et al.
Publicado: (2016)

An Agrobacterium‐delivered CRISPR/Cas9 system for targeted mutagenesis in sorghum
por: Char, Si Nian, et al.
Publicado: (2019)

Targeted mutagenesis in tetraploid switchgrass (Panicum virgatum L.) using CRISPR/Cas9
por: Liu, Yang, et al.
Publicado: (2017)

Roles of XRCC2, RAD51B and RAD51D in RAD51-Independent SSA Recombination
por: Serra, Heïdi, et al.
Publicado: (2013)

TOPBP1 regulates RAD51 phosphorylation and chromatin loading and determines PARP inhibitor sensitivity
por: Moudry, Pavel, et al.
Publicado: (2016)

KIAA1529 regulates RAD51 expression to confer PARP inhibitors resistance in ovarian cancer
por: Qiao, Yuan, et al.
Publicado: (2022)

RAD51D Secondary Mutation-Mediated Resistance to PARP-Inhibitor-Based Therapy in HGSOC
por: Xu, Jing, et al.
Publicado: (2023)

CRISPR/Cas9-Targeted Mutagenesis in Caenorhabditis elegans
por: Waaijers, Selma, et al.
Publicado: (2013)

CRISPR/Cas-Mediated Targeted Mutagenesis in Daphnia magna
por: Nakanishi, Takashi, et al.
Publicado: (2014)

Targeted mutagenesis in rice using CRISPR-Cas system
por: Miao, Jin, et al.
Publicado: (2013)

Targeted mutagenesis using CRISPR/Cas system in medaka
por: Ansai, Satoshi, et al.
Publicado: (2014)

CRISPR-Cas9-Mediated Mutagenesis: Mind the Gap?
por: Teboul, Lydia, et al.
Publicado: (2018)

CRISPR/Cas9-mediated targeted mutagenesis in grape
por: Nakajima, Ikuko, et al.
Publicado: (2017)

CRISPR–Cas-mediated transcriptional control and epi-mutagenesis
por: Gardiner, Jason, et al.
Publicado: (2022)

CRISPR/Cas9‐mediated saturated mutagenesis of the cotton MIR482 family for dissecting the functionality of individual members in disease response
por: Zhu, Qian‐Hao, et al.
Publicado: (2022)

Structure and function of the RAD51B-RAD51C-RAD51D-XRCC2 tumour suppressor
por: Greenhough, Luke A., et al.
Publicado: (2023)

Repression of LSD1 potentiates homologous recombination-proficient ovarian cancer to PARP inhibitors through down-regulation of BRCA1/2 and RAD51
por: Tao, Lei, et al.
Publicado: (2023)

Homologous Pairing Activities of Two Rice RAD51 Proteins, RAD51A1 and RAD51A2
por: Morozumi, Yuichi, et al.
Publicado: (2013)

FBI-1 enhanced the resistance of triple-negative breast cancer cells to chemotherapeutic agents via the miR-30c/PXR axis
por: Yang, Hua, et al.
Publicado: (2020)

CRISPR/Cas9‐mediated mutagenesis to validate the synergy between PARP1 inhibition and chemotherapy in BRCA1‐mutated breast cancer cells
por: Mintz, Rachel L., et al.
Publicado: (2020)

CRISPR/Cas9-Mediated Efficient Targeted Mutagenesis in Sesame (Sesamum indicum L.)
por: You, Jun, et al.
Publicado: (2022)

PARP1 and PARP2 stabilise replication forks at base excision repair intermediates through Fbh1-dependent Rad51 regulation
por: Ronson, George E., et al.
Publicado: (2018)

Targeted mutagenesis in soybean using the CRISPR-Cas9 system
por: Sun, Xianjun, et al.
Publicado: (2015)

Targeted mutagenesis in chicken using CRISPR/Cas9 system
por: Oishi, Isao, et al.
Publicado: (2016)

CRISPR/Cas9 Mediates Efficient Conditional Mutagenesis in Drosophila
por: Xue, Zhaoyu, et al.
Publicado: (2014)

CRISPR-Cas9 enables conditional mutagenesis of challenging loci
por: Schick, Joel A., et al.
Publicado: (2016)

Targeted mutagenesis in wheat microspores using CRISPR/Cas9
por: Bhowmik, Pankaj, et al.
Publicado: (2018)

CRISPR/Cas9-Mediated Mutagenesis of RCO in Cardamine hirsuta
por: Alvim Kamei, Claire Lessa, et al.
Publicado: (2020)

CRISPR/Cas9 Targeted Mutagenesis for Functional Genetics in Maize
por: Hunter, Charles T.
Publicado: (2021)

Generation of a multiplex mutagenesis population via pooled CRISPR‐Cas9 in soya bean
por: Bai, Mengyan, et al.
Publicado: (2019)

Rad51 paralogs Rad55-Rad57 balance the anti-recombinase Srs2 in Rad51 filament formation
por: Liu, Jie, et al.
Publicado: (2011)

An Agrobacterium‐delivered CRISPR/Cas9 system for high‐frequency targeted mutagenesis in maize
por: Char, Si Nian, et al.
Publicado: (2016)

Rad51 inhibition sensitizes breast cancer stem cells to PARP inhibitor in triple-negative breast cancer
por: Wang, Dong, et al.
Publicado: (2017)

Dual PARP and RAD51 Inhibitory Drug Conjugates Show Synergistic and Selective Effects on Breast Cancer Cells
por: Malka, Matthews M., et al.
Publicado: (2021)

PG545 sensitizes ovarian cancer cells to PARP inhibitors through modulation of RAD51-DEK interaction
por: Ray, Upasana, et al.
Publicado: (2023)

Contributions of the RAD51 N-terminal domain to BRCA2-RAD51 interaction
por: Subramanyam, Shyamal, et al.
Publicado: (2013)

RAD51AP1 mediates RAD51 activity through nucleosome interaction
por: Pires, Elena, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_frb78806idlj9r6pra4mm7io9i